Crinetics Pharmaceuticals, Inc. (CRNX)

36.27 +1.33 (+3.81%) USD  |  NASDAQ  |  May 20, 16:00
36.60 +0.33 (+0.91%) Pre-Market: 09:17
More

Crinetics Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CRNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Amneal Pharmaceuticals, Inc. Upgrade
Aquestive Therapeutics, Inc. Upgrade
Merck & Co., Inc. Upgrade
Nektar Therapeutics Upgrade
Prestige Consumer Healthcare, Inc. Upgrade